| 制药企业对我国药品可及性工作作用研究 |
| |
| 引用本文： | 席晓宇,胡晨希,褚淑贞.制药企业对我国药品可及性工作作用研究[J].药品评价,2010,7(22):9-13. |
| |
| 作者姓名： | 席晓宇 胡晨希 褚淑贞 |
| |
| 作者单位： | 中国药科大学医药产业发展研究中心,南京211198 |
| |
| 摘 要： | 目的：论证制药企业这一特殊市场主体在保障药品可及性工作中的重要作用。方法：通过规制经济学外部性与外部性分析探讨了制药企业在提高药品可及性工作中的影响，并对制药企业在我国药品可及性工作中的六方面工作重点进行了分析。结果与结论：制药企业对于我国药品可及性工作具有重要作用，并且开展这项工作也会对企业带来利益。
|
| 关 键 词： | 制药企业 药品可及性 |
The Research on the Function of Pharmaceutical Corporation in the Drug Access Programme in China |
| |
| XI Xiao-Yu,HU Chen-xi,CHU Shu-zhen.The Research on the Function of Pharmaceutical Corporation in the Drug Access Programme in China[J].Drug Evaluation,2010,7(22):9-13. |
| |
| Authors: | XI Xiao-Yu HU Chen-xi CHU Shu-zhen |
| |
| Institution: | ( Medical Industry Development Research Center, China Pharmaceutical University, Nanjing 211198) |
| |
| Abstract: | Objective： To discuss the important role that the pharmaceutical corporations play in the drug access programme. Methods： Using the regulation economic methods and the external analysis, discussion was made on the influence of pharmaceutical corporations＇ increasing the drug access programme, and analysis was made on six aspects. Results and Conclusion： The pharmaceutical corporations can play an important role in the drug access programme in China, and this work will bring benefits to the enterprises, too. |
| |
| Keywords: | Pharmaceutical Corporation Drug Access Programme |
| 本文献已被 维普 万方数据 等数据库收录！ |
